Abstract

Using all-atom explicit solvent replica exchange molecular dynamics simulations with solute tempering, we study the effect of methionine oxidation on Aβ10–40 peptide binding to the zwitterionic DMPC bilayer. By comparing oxidized and reduced peptides, we identified changes in the binding mechanism caused by this modification. First, Met35 oxidation unravels C-terminal helix in the bound peptides. Second, oxidation destabilizes intrapeptide interactions and expands bound peptides. We explain these outcomes by the loss of amphiphilic character of the C-terminal helix due to oxidation. Third, oxidation “polarizes” Aβ binding to the DMPC bilayer by strengthening the interactions of the C-terminus with lipids while largely releasing the rest of the peptide from bilayer. Fourth, in contrast to the wild-type peptide, oxidized Aβ induces significantly smaller bilayer thinning and drop in lipid density within the binding footprint. These observations are the consequence of mixing oxidized peptide amino acids with lipids promoted by enhanced Aβ conformational fluctuations. Fifth, methionine oxidation reduces the affinity of Aβ binding to the DMPC bilayer by disrupting favorable intrapeptide interactions upon binding, which offset the gains from better hydration. Reduced binding affinity of the oxidized Aβ may represent the molecular basis for its reduced cytotoxicity.

Highlights

  • Progression of Alzheimer’s disease is related to the accumulation of cytotoxic Aβ peptides[1], which are naturally cleaved from membrane-spanning β-amyloid precursor proteins by β and γ secretases[2]

  • To gain insight into the changes in binding mechanism attributed to oxidation, we compare binding of methionine oxidized (MetO) Aβ10–40 to the binding of wild-type (WT) Aβ10–40 to the same bilayer studied by us previously[29]

  • Using all-atom explicit solvent replica exchange molecular dynamics simulations with solute tempering, we showed that methionine oxidation changes the mechanism of Aβ10–40 peptide binding to the DMPC bilayer

Read more

Summary

Introduction

Progression of Alzheimer’s disease is related to the accumulation of cytotoxic Aβ peptides[1], which are naturally cleaved from membrane-spanning β-amyloid precursor proteins by β and γ secretases[2] This process results in the extracellular release of several Aβ alloforms, of which the 40-residue monomer Aβ1–40 is most prevalent[3]. Most experimental studies indicate that, compared to wild-type (WT) Aβ, methionine oxidation impairs formation of aggregated Aβ species[13,14,15]. This outcome is predominately associated with a decreased rate of assembly[14,16] delaying cytotoxic effects[17,18]. CD and NMR spectroscopy have been used www.nature.com/scientificreports/

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call